SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-122422
Filing Date
2019-04-26
Accepted
2019-04-26 16:22:56
Documents
16
Period of Report
2019-06-05
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d683923ddef14a.htm DEF 14A 362824
2 GRAPHIC g6839231.jpg GRAPHIC 32782
3 GRAPHIC g6839231a.jpg GRAPHIC 42273
4 GRAPHIC g683923g02l56.jpg GRAPHIC 33906
5 GRAPHIC g683923g25f08.jpg GRAPHIC 33923
6 GRAPHIC g683923g29r76.jpg GRAPHIC 30425
7 GRAPHIC g683923im10.jpg GRAPHIC 3421
8 GRAPHIC g683923im11.jpg GRAPHIC 12177
9 GRAPHIC g683923im12.jpg GRAPHIC 3068
10 GRAPHIC g683923im3.jpg GRAPHIC 2616
11 GRAPHIC g683923im4.jpg GRAPHIC 7016
12 GRAPHIC g683923im5.jpg GRAPHIC 2328
13 GRAPHIC g683923im6.jpg GRAPHIC 3517
14 GRAPHIC g683923im7.jpg GRAPHIC 20892
15 GRAPHIC g683923im8.jpg GRAPHIC 44030
16 GRAPHIC g683923im9.jpg GRAPHIC 3390
  Complete submission text file 0001193125-19-122422.txt   734422
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38266 | Film No.: 19772055
SIC: 2834 Pharmaceutical Preparations